Terms: = Brain cancer AND KDM6A, O15550, UTX, 7403, ENSG00000147050, DKFZp686A03225, RP13-886N14_3, MGC141941, bA386N14_2 AND Clinical Outcome
850 results:
1. Microsurgical removal of supratentorial and cerebellar cavernous malformations: what has changed? A single institution experience.
Meneghelli P; Pasqualin A; Musumeci A; Pinna G; Berti PP; Polizzi GMV; Sinosi FA; Nicolato A; Sala F
J Clin Neurosci; 2024 May; 123():162-170. PubMed ID: 38581776
[TBL] [Abstract] [Full Text] [Related]
2. [
Pruis IJ; Verburg FA; Balvers RK; Harteveld AA; Feelders RA; Vernooij MW; Smits M; Neggers SJCMM; Veldhuijzen van Zanten SEM
J Nucl Med; 2024 May; 65(5):688-692. PubMed ID: 38514085
[TBL] [Abstract] [Full Text] [Related]
3. Relevance of mutations in protein deubiquitinases genes and
Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
[TBL] [Abstract] [Full Text] [Related]
4. [Neurosurgical treatment of tumors of the pineal region - literature review and overview of cases at OMIII].
Mezei T; Báskay J; Pollner P; Kovács V; Markia B; Nagy G; Bajcsay A; Sipos L
Magy Onkol; 2024 Mar; 68(1):27-35. PubMed ID: 38484373
[TBL] [Abstract] [Full Text] [Related]
5. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
Donev K; Sundararajan V; Johnson D; Balan J; Chambers M; Paulson VA; Scherpelz KP; Abdullaev Z; Quezado M; Cimino PJ; Pratt D; Valerio E; Alves de Castro JV; Carraro DM; Torrezan GT; Wolff BM; Kulikowski LD; Costa FD; Aldape K; Ida CM
J Neuropathol Exp Neurol; 2024 Apr; 83(5):357-364. PubMed ID: 38447592
[TBL] [Abstract] [Full Text] [Related]
6. Effect of continuous hypertonic saline infusion on clinical outcomes in patients with traumatic brain injury.
Peng C; Chi L; Chen M; Peng L; Yang F; Shao L; Bo L; Jin Z
Neurosurg Rev; 2024 Feb; 47(1):78. PubMed ID: 38340147
[TBL] [Abstract] [Full Text] [Related]
7. Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature.
Kritikos M; Vivanco-Suarez J; Teferi N; Lee S; Kato K; Eschbacher KL; Bathla G; Buatti JM; Hitchon PW
Neurosurg Rev; 2024 Feb; 47(1):75. PubMed ID: 38319484
[TBL] [Abstract] [Full Text] [Related]
8. GammaTile
Yekula A; Gessler DJ; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
J Neurooncol; 2024 Feb; 166(3):441-450. PubMed ID: 38281303
[TBL] [Abstract] [Full Text] [Related]
9. National multicentered retrospective review of clinical and intraoperative factors associated with the development of cerebellar mutism after pediatric posterior fossa tumor resection.
Kameda-Smith MM; Ragulojan M; Elliott C; Bliss L; Moore H; Sader N; Alsuwaihel M; Tso MK; Dakson A; Ajani O; Yarascavitch B; Fleming A; Mehta V; Aminnejad M; Farrokhyar F; Singh SK;
Childs Nerv Syst; 2024 May; 40(5):1339-1347. PubMed ID: 38279985
[TBL] [Abstract] [Full Text] [Related]
10. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
11. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
[TBL] [Abstract] [Full Text] [Related]
12. The Application of Sodium Fluorescein in Resection of Medulloblastoma Under YELLOW 560 Filter: Feasibility and Preliminary Results of a Monocentric Cohort and Systematic Review.
Falco J; Broggi M; Rubiu E; Schiariti M; Restelli F; Mazzapicchi E; La Corte E; Ferroli P; Acerbi F
World Neurosurg; 2024 Mar; 183():e386-e394. PubMed ID: 38154682
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcome Assessments in Encephalitis: A Systematic Review.
Brenner J; Olijslagers SHC; Crijnen YS; de Vries JM; Mandarakas MR; Titulaer MJ
Neurol Neuroimmunol Neuroinflamm; 2024 Jan; 11(1):e200168. PubMed ID: 38086078
[TBL] [Abstract] [Full Text] [Related]
14. clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
[TBL] [Abstract] [Full Text] [Related]
15. PATIENT-RELATED FACTORS AND clinical MANAGEMENT outcomeS OF RETINOBLASTOMA IN CALABAR, NIGERIA.
Nkanga ED; Nlemadim AC; Arazi M; Nkanga DG; Duke RE; Fabian ID; Nkanga ED; Odey FA; Meremikwu MM
West Afr J Med; 2023 Dec; 40(12 Suppl 1):S36-S37. PubMed ID: 38070170
[TBL] [Abstract] [Full Text] [Related]
16. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
17. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS; Aherrahrou Z; Grasshoff H; Heidorn MW; Humrich JY; Johanson L; Aherrahrou R; Reinberger T; Schulz A; Ten Cate V; Robles AP; Koeck T; Rapp S; Lange T; Brachaczek L; Luebber F; Erdmann J; Heidecke H; Schulze-Forster K; Dechend R; Lackner KJ; Pfeiffer N; Ghaemi Kerahrodi J; Tüscher O; Schwarting A; Strauch K; Münzel T; Prochaska JH; Riemekasten G; Wild PS
Eur Heart J; 2023 Dec; 44(47):4935-4949. PubMed ID: 37941454
[TBL] [Abstract] [Full Text] [Related]
18. Subarachnoid hemorrhage due to pituitary adenoma apoplexy-case report and review of the literature.
Yildiz Y; Lauber A; Char NV; Bozinov O; Neidert MC; Hostettler IC
Neurol Sci; 2024 Mar; 45(3):997-1005. PubMed ID: 37872321
[TBL] [Abstract] [Full Text] [Related]
19. Prevalence and clinical correlations of SF3B1 variants in lactotroph tumours.
Simon J; Perez-Rivas LG; Zhao Y; Chasseloup F; Lasolle H; Cortet C; Descotes F; Villa C; Baussart B; Burman P; Maiter D; von Selzam V; Rotermund R; Flitsch J; Thorsteinsdottir J; Jouanneau E; Buchfelder M; Chanson P; Raverot G; Theodoropoulou M
Eur J Endocrinol; 2023 Sep; 189(3):372-378. PubMed ID: 37721395
[TBL] [Abstract] [Full Text] [Related]
20. Effect of nitrous oxide on clinical outcome in patients undergoing cerebellopontine tumor surgery under sevoflurane anesthesia: a randomized controlled trial.
Bindu B; Singh GP; Pandia MP
Med Gas Res; 2024; 14(1):26-32. PubMed ID: 37721252
[TBL] [Abstract] [Full Text] [Related]
[Next]
